American Capital Advisory’s Envoy Medical COCH Stock Holding History

American Capital Advisory’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58K	Hold	2,000	–	–	﹤0.01%	681
2026 Q1	$1.33K	Hold	2,000	–	–	﹤0.01%	610
2025 Q4	$1.32K	Hold	2,000	–	–	﹤0.01%	534
2025 Q3	$1.55K	Hold	2,000	–	–	﹤0.01%	472
2025 Q2	$2.84K	Hold	2,000	–	–	﹤0.01%	387
2025 Q1	$2.6K	Hold	2,000	–	–	﹤0.01%	376
2024 Q4	$2.86K	Hold	2,000	–	–	﹤0.01%	389
2024 Q3	$6.5K	Buy	+2,000	New	+$5.44K	﹤0.01%	327

Other funds holding COCH

DCA

DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AFS

AFG Fiduciary Services Hingham, Massachusetts $128M AUM 24.3% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Ballew Advisors Jackson, Mississippi $194M AUM 20.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

American Capital Advisory's COCH Position: Q2 2026 in Review

American Capital Advisory held its Envoy Medical (COCH) position steady in Q2 2026 at 2,000 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

American Capital Advisory first reported a position in COCH in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.5K in Q3 2024. 10 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

American Capital Advisory held 2,000 shares of Envoy Medical worth $1.58K as of Q2 2026.
American Capital Advisory left its Envoy Medical share count unchanged in Q2 2026.
Envoy Medical made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #681 holding.
American Capital Advisory first reported a position in Envoy Medical in Q3 2024 and has held it in 8 quarters since.
American Capital Advisory's Envoy Medical position peaked at $6.5K in Q3 2024.
10 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.